Serum Mesothelin and Other Biomarkers: What Have We Learned in the Last Decade?

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2017.10.132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

The RCS ESOS Course: What Have We Learned and What Have We to Offer Other Course Organisers?

The Bulletin of the Royal College of Surgeons of England
2011English

What We Have Learned From a Decade of ED Crowding Research

Academic Emergency Medicine
MedicineEmergency Medicine
2015English

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far

Frontiers in Genetics
GeneticsMolecular Medicine
2018English

EuReCa_Serbia: What Have We Learned?

Journal Resuscitatio Balcanica
2019English

What Have We Learned From a Decade of Manufacturing Enterprise Surveys in Africa ?

Policy Research Working Papers
2005English

What We Have Learned and How We May Proceed

International Studies in Entrepreneurship
2020English

What Have We Learned, So Far?

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2002English

What We Have Learned From Ribosome Structures

Biochemical Society Transactions
Biochemistry
2008English

Residual Macrovascular Risk in 2013: What Have We Learned?

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy